First Wave BioPharma Inc logo

First Wave BioPharma Inc

$ 0.80 +0.115 (+16.91%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 4.61M
Enterprise V:
$ 2.58M
Volume:
465.52K
Avg Vol (2M):
948.12K
Also Trade In:
Volume:
465.52K
Market Cap $:
4.61M
PE Ratio:
At Loss
Avg Vol (2-Month):
948.12K
Enterprise Value $:
2.58M
PB Ratio:
0
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
First Wave BioPharma Inc is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. It is advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies-niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.
Name Current Vs Industry Vs History
Cash-To-Debt 5.62
Equity-to-Asset -0.49
Debt-to-Equity -0.13
Debt-to-EBITDA -0.01
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 7.7
3-Year EPS without NRI Growth Rate -2.5
3-Year FCF Growth Rate 12.6
Name Current Vs Industry Vs History
5-Day RSI 57.67
9-Day RSI 42.79
14-Day RSI 36.65
6-1 Month Momentum % -89.75
12-1 Month Momentum % -98.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.38
Quick Ratio 0.38
Cash Ratio 0.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -103.2
Name Current Vs Industry Vs History
ROA % -262.14
ROIC % -408.77
ROC (Joel Greenblatt) % -5704.87

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.12
EV-to-EBITDA -0.12
EV-to-Forward-Revenue -64.47
EV-to-FCF -0.11
Earnings Yield (Greenblatt) % -833.33

Financials (Next Earnings Date:2023-02-15 Est.)

FWBI's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FWBI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -19.49
Beta 1.65
Volatility % 50.02
14-Day RSI 36.65
14-Day ATR ($) 0.133329
20-Day SMA ($) 0.864255
12-1 Month Momentum % -98.06
52-Week Range ($) 0.6301 - 81.9
Shares Outstanding (Mil) 5.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

First Wave BioPharma Inc Filings

Document Form Filing Date
No Filing Data

First Wave BioPharma Inc Analysis

Share your research

Headlines

See More
No news.